The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.
Open accessAbstract
Insulin-dependent diabetes mellitus (IDDM) is thought to be an immunologically mediated disease resulting in the complete destruction of the insulin-producing islets of Langerhans. It has become increasingly clear that autoreactive T cells play a major role in the development and progression of this disease. In this study, we examined the role of the CD28/B7 costimulation pathway in the development and progression of autoimmune diabetes in the nonobese diabetic (NOD) mouse model. Female NOD mice treated at the onset of insulitis (2-4 wk of age) with CTLA4Ig immunoglobulin (Ig) (a soluble CD28 antagonist) or a monoclonal antibody (mAb) specific for B7-2 (a CD28 ligand) did not develop diabetes. However, neither of these treatments altered the disease process when administered late, at > 10 wk of age. Histological examination of islets from the various treatment groups showed that while CTLA4Ig and anti-B7-2 mAb treatment blocked the development of diabetes, these reagents had little effect on the development or severity of insulitis. Together these results suggest that blockade of costimulatory signals by CTLA4Ig or anti-B7-2 acts early in disease development, after insulitis but before the onset of frank diabetes. NOD mice were also treated with mAbs to another CD28 ligand, B7-1. In contrast to the previous results, the anti-B7-1 treatment significantly accelerated the development of disease in female mice and, most interestingly, induced diabetes in normally resistant male mice. A combination of anti-B7-1 and anti-B7-2 mAbs also resulted in an accelerated onset of diabetes, similar to that observed with anti-B7-1 mAb treatment alone, suggesting that anti-B7-1 mAb's effect was dominant. Furthermore, treatment with anti-B7-1 mAbs resulted in a more rapid and severe infiltrate. Finally, T cells isolated from the pancreas of these anti-B7-1-treated animals exhibited a more activated phenotype than T cells isolated from any of the other treatment groups. These studies demonstrate that costimulatory signals play an important role in the autoimmune process, and that different members of the B7 family have distinct regulatory functions during the development of autoimmune diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Self-citationCTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Kuchroo, V. K., Prabhu Das, M., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., & Glimcher, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90349-6 · Cited by 1,641
Self-citationHarding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Jenkins, M. K., & Schwartz, R. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.2.302 · Cited by 1,170
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
Self-citationKaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., & Lehmann, P. V. (1993) · Nature · doi:10.1038/366069a0 · Cited by 1,070
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
Tisch, R., Yang, X.-D., Singer, S. M., Liblau, R. S., Fugger, L., & McDevitt, H. O. (1993) · Nature · doi:10.1038/366072a0 · Cited by 949
B70 antigen is a second ligand for CTLA-4 and CD28
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L., & Somoza, C. (1993) · Nature · doi:10.1038/366076a0 · Cited by 909
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Lombard, L. A., Gray, G. S., & Nadler, L. M. (1993) · Science · doi:10.1126/science.7694363 · Cited by 902
Self-citationImmunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., & Tepper, M. A. (1992) · Science · doi:10.1126/science.1496399 · Cited by 790
T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
Linsley, P. S., Clark, E. A., & Ledbetter, J. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5031 · Cited by 747
Following a diabetogenic T cell from genesis through pathogenesis
Katz, J. D., Wang, B., Haskins, K., Benoist, C., & Mathis, D. (1993) · Cell · doi:10.1016/0092-8674(93)90730-e · Cited by 696
Role of the CD28 receptor in T-cell activation
June, C. H., Ledbetter, J. A., Linsley, P. S., & Thompson, C. B. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90085-n · Cited by 676
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P., & Hodes, R. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.631 · Cited by 669
Treatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 668
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
Thompson, C. B., Lindsten, T., Ledbetter, J. A., Kunkel, S. L., Young, H. A., Emerson, S. G., Leiden, J. M., & June, C. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1333 · Cited by 659
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat
Castano, L., & Eisenbarth, G. S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003243 · Cited by 644
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C., & Damle, N. K. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1595 · Cited by 581
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S., & Gordon, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11102 · Cited by 533
Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation
Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P., & Hodes, R. J. (1993) · Science · doi:10.1126/science.7694361 · Cited by 517
B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.
Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F., & Nadler, L. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2714 · Cited by 476
Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C., & Nadler, L. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6575 · Cited by 427
Acceleration of Diabetes in Young Nod Mice with a CD4 + Islet-specific T Cell Clone
Haskins, K., & McDuffie, M. (1990) · Science · doi:10.1126/science.2205920 · Cited by 382
Absence of B7-dependent responses in CD28-deficient mice
Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G. S., Bluestone, J. A., & Thompson, C. B. (1994) · Immunity · doi:10.1016/1074-7613(94)90092-2 · Cited by 376
Self-citationUncovering of Functional Alternative CTLA-4 Counter-Receptor in B7-Deficient Mice
Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L., Lombard, D. B., et al. (1993) · Science · doi:10.1126/science.7694362 · Cited by 359
Self-citationFreeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Gribben, J. G., Ng, J. W., Kim, J., Goldberg, J. M., Hathcock, K., & Laszlo, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2185 · Cited by 351
NOD mouse colonies around the world- recent facts and figures
Pozzilli, P., Signore, A., Williams, A. J. K., & Beales, P. E. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90160-m · Cited by 349
Immunotherapy of the Nonobese Diabetic Mouse: Treatment with an Antibody to T-Helper Lymphocytes
Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K., & Fathman, C. G. (1988) · Science · doi:10.1126/science.2966437 · Cited by 345
Freedman, A. S., Freeman, G. J., Rhynhart, K., & Nadler, L. M. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90091-o · Cited by 312
Identification and distribution of the costimulatory receptor CD28 in the mouse
Gross, J. A., Callas, E., & Allison, J. P. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.380 · Cited by 309
Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations.
Larsen, C. P., Ritchie, S. C., Pearson, T. C., Linsley, P. S., & Lowry, R. P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1215 · Cited by 302
Lenschow, D. J., Sperling, A. I., Cooke, M. P., Freeman, G., Rhee, L., Decker, D. C., Gray, G., Nadler, L. M., Goodnow, C. C., & Bluestone, J. A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.5.1990 · Cited by 290
Self-citationT cell activation via Leu-23 (CD69).
Testi, R., Phillips, J. H., & Lanier, L. L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1123 · Cited by 290
Nabavi, N., Freeman, G. J., Gault, A., Godfrey, D., Nadler, L. M., & Glimcher, L. H. (1992) · Nature · doi:10.1038/360266a0 · Cited by 280
Self-citationFunctional expression of B7/BB1 on activated T lymphocytes.
Azuma, M., Yssel, H., Phillips, J. H., Spits, H., & Lanier, L. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.845 · Cited by 267
Expression and functional significance of an additional ligand for CTLA-4.
Lenschow, D. J., Su, G. H., Zuckerman, L. A., Nabavi, N., Jellis, C. L., Gray, G. S., Miller, J., & Bluestone, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11054 · Cited by 259
Self-citationAutoimmune diabetes as a consequence of locally produced interleukin-2
Heath, W. R., Allison, J., Hoffmann, M. W., Schönrich, G., Hämmerling, G., Arnold, B., & Miller, J. F. A. P. (1992) · Nature · doi:10.1038/359547a0 · Cited by 236
Miyazaki, A., Hanafusa, T., Yamada, K., Miyagawa, J., Fujino-Kurihara, H., Nakajima, H., Nonaka, K., & Tarui, S. (1985) · PubMed Central · Cited by 235
Preventive Effect of Monoclonal Anti-L3T4 Antibody on Development of Diabetes in NOD Mice
Koike, T., Itoh, Y., Ishii, T., Ito, I., Takabayashi, K., Maruyama, N., Tomioka, H., & Yoshida, S. (1987) · Diabetes · doi:10.2337/diab.36.4.539 · Cited by 213
B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman, A. S., Freeman, G., Horowitz, J. C., Daley, J., & Nadler, L. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.10.3260 · Cited by 207
Boussiotis, V. A., Freeman, G. J., Gribben, J. G., Daley, J., Gray, G., & Nadler, L. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11059 · Cited by 203
Self-citationGuarder, S., Meyerhoff, J., & Flavell, R. (1994) · Immunity · doi:10.1016/1074-7613(94)90109-0 · Cited by 170
CD28 ligation in T-cell activation: evidence for two signal transduction pathways.
Ledbetter, J., Imboden, J., Schieven, G., Grosmaire, L., Rabinovitch, P., Lindsten, T., Thompson, C., & June, C. (1990) · Blood · doi:10.1182/blood.v75.7.1531.1531 · Cited by 170
Harlan, D. M., Hengartner, H., Huang, M. L., Kang, Y. H., Abe, R., Moreadith, R. W., Pircher, H., Gray, G. S., Ohashi, P. S., & Freeman, G. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3137 · Cited by 159
Self-citationSchwartz, R. H., Mueller, D. L., Jenkins, M. K., & Quill, H. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.072 · Cited by 159
Gross, J. A., John, T. S., & Allison, J. P. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.3201 · Cited by 154
O’Reilly, L. A., Hutchings, P. R., Crocker, P. R., Simpson, E., Lund, T., Kioussis, D., Takei, F., BAIRD, J. D., & Cooke, A. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210512 · Cited by 141
Risso, A., Smilovich, D., Capra, M. C., Baldissarro, I., Yan, G., Bargellesi, A., & Cosulich, M. E. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.12.4105 · Cited by 128
Functional characterization of an antigen involved in an early step of T-cell activation.
Cosulich, M. E., Rubartelli, A., Risso, A., Cozzolino, F., & Bargellesi, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.12.4205 · Cited by 122
Burkly, L. C., Lo, D. D., & Flavell, R. A. (1990) · Science · doi:10.1126/science.1694042 · Cited by 111
Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
Peterson, J. D., Pike, B. L., MCDUFFIE, M. J., & HASKINS, K. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2800 · Cited by 49
Cited by
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Self-citationINDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative Approaches
Constant, S. L., & Bottomly, K. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.297 · Cited by 1,459
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
Metadata
- Authors
- Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C., & Bluestone, J. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1995-03-01
- Volume
- 181
- Issue
- 3
- Pages
- 1145-1155
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2138212565
- Cited by
- 583
- References
- 54
- FWCI
- 30.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.